Verge Genomics Appoints Tony Altar, Ph.D., as Chief Scientific Officer

Tony Altar, Ph.D., brings to Verge more than 35 years of experience leading various drug discovery and development teams in neuroscience.

Link to Full Article

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!